Zenotech Laboratories (BOM:532039) Cash Flow for Dividends: ₹0.0 Mil (TTM As of Mar. 2026)


BOM:532039 Zenotech Laboratories Ltd BOM:532039
73 GF Score
Price ₹44.59
GF Value ₹65.21
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Zenotech Laboratories Cash Flow for Dividends?

Zenotech Laboratories BOM:532039 -0.96% 73 Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:532039 with a GF Score™ of 73/100 and a GF Value™ of ₹65.21 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Zenotech Laboratories's cash flow for dividends for the three months ended in Mar. 2026 was ₹0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Zenotech Laboratories Cash Flow for Dividends Related Terms

Zenotech Laboratories Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Zenotech Laboratories's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenotech Laboratories Cash Flow for Dividends Chart

Zenotech Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Zenotech Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:532039
73GF Score
Zenotech Laboratories Ltd BOM:532039
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenotech Laboratories Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ₹0.0 Mil mean?
Zenotech Laboratories (BOM:532039) has a Cash Flow for Dividends of ₹0.0 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Zenotech Laboratories and its competitors.
Is Zenotech Laboratories' Cash Flow for Dividends too high?
Zenotech Laboratories' current Cash Flow for Dividends is ₹0.0 Mil. Overall, Zenotech Laboratories has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenotech Laboratories' Cash Flow for Dividends compare to ZTS and UTHR?
Zenotech Laboratories' Cash Flow for Dividends of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Zenotech Laboratories and its competitors. Zenotech Laboratories's current Cash Flow for Dividends is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenotech Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Zenotech Laboratories (BOM:532039) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹65.21, compared to a current price of ₹44.59 — trading 31.6% below its estimated fair value. The current Cash Flow for Dividends is ₹0.0 Mil. Zenotech Laboratories' overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Zenotech Laboratories (BOM:532039), the current Cash Flow for Dividends is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenotech Laboratories (BOM:532039) Overvalued in 2026?

Based on GuruFocus' analysis, Zenotech Laboratories stock appears to be undervalued. The current stock price of ₹44.59 is trading 31.6% below its estimated GF Value™ of ₹65.21. GuruFocus considers Zenotech Laboratories to be Significantly Undervalued.

Key valuation signals for BOM:532039:

  • Cash Flow for Dividends: ₹0.0 Mil
  • GF Value™: ₹65.21 vs. price of ₹44.59 (31.6% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the BOM:532039 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenotech Laboratories Business Description

Address Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.
73GF Score

Get the complete analysis for BOM:532039

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹44.59
Price
₹65.21
GF Value